Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic ...
Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight years before dying.
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Study Finds on MSN1d
Researchers uncover serious flaw in promising Alzheimer’s blood testsNew research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...
Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...
AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...
MedPage Today on MSN1d
Alzheimer's Research Funds in Limbo; X Chromosome and the Brain; Stress and StrokeAt least $65 million slated for 14 of 35 Alzheimer's disease research centers is in limbo, with funding expected to run out ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback